Michael Adatto - Net Worth and Insider Trading

Michael Adatto Net Worth

The estimated net worth of Michael Adatto is at least $3 Million dollars as of 2024-05-06. Michael Adatto is the SVP, Managed Care & Comm. Dev. of Horizon Therapeutics PLC and owns about 22,911 shares of Horizon Therapeutics PLC (HZNP) stock worth over $3 Million. Details can be seen in Michael Adatto's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Adatto has not made any transactions after 2013-01-02 and currently still holds the listed stock(s).

Transaction Summary of Michael Adatto

To

Michael Adatto Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Adatto owns 1 companies in total, including Horizon Therapeutics PLC (HZNP) .

Click here to see the complete history of Michael Adatto’s form 4 insider trades.

Insider Ownership Summary of Michael Adatto

Ticker Comapny Transaction Date Type of Owner
HZNP Horizon Therapeutics PLC 2013-01-02 SVP & Sales & Managed Care

Michael Adatto Latest Holdings Summary

Michael Adatto currently owns a total of 1 stock. Michael Adatto owns 22,911 shares of Horizon Therapeutics PLC (HZNP) as of January 2, 2013, with a value of $3 Million.

Latest Holdings of Michael Adatto

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HZNP Horizon Therapeutics PLC 2013-01-02 22,911 116.30 2,664,549

Holding Weightings of Michael Adatto


Michael Adatto Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Adatto has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the sale of 6,998 shares on January 2, 2013, which brought Michael Adatto around $16,515.

Insider Trading History of Michael Adatto

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Adatto Trading Performance

GuruFocus tracks the stock performance after each of Michael Adatto's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Adatto is -43.25%. GuruFocus also compares Michael Adatto's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Adatto within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Adatto's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Adatto

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -40.5
Relative Return to S&P 500(%) -37.93

Michael Adatto Ownership Network

Ownership Network List of Michael Adatto

No Data

Ownership Network Relation of Michael Adatto


Michael Adatto Owned Company Details

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Michael Adatto is the SVP & Sales & Managed Care of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

Over the past 18 months, Michael Adatto made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Horizon Therapeutics PLC Insider Transactions

No Available Data

Michael Adatto Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Adatto. You might contact Michael Adatto via mailing address: 1033 Skokie Boulevard, Suite 355, Northbrook Il 60062.

Discussions on Michael Adatto

No discussions yet.